openPR Logo
Press release

Investigation announced for Long-Term Investors in Fulgent Genetics, Inc. (NASDAQ: FLGT)

01-31-2023 04:36 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Fulgent Genetics, Inc. (NASDAQ: FLGT) shares.

An investigation on behalf of current long term investors in Fulgent Genetics, Inc. (NASDAQ: FLGT) shares.

An investigation was announced for long-term investors in shares of Fulgent Genetics, Inc. (NASDAQ: FLGT) concerning potential breaches of fiduciary duties by certain directorsofficers of Fulgent Genetics, Inc.

Investors who are current long term investors in Fulgent Genetics, Inc. (NASDAQ: FLGT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: FLGT stocks follows a lawsuit filed against Fulgent Genetics, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in Fulgent Genetics, Inc. (NASDAQ: FLGT stocks, concerns whether certain Fulgent Genetics, Inc. directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Central District of California the plaintiff alleges that, the Defendants made false and/or misleading statements and/or failed to disclose that Fulgent Genetics, Inc had been conducting medically unnecessary laboratory testing, engaging in improper billing practices in relation to laboratory testing, and providing or receiving remuneration in violation of the Anti-Kickback Statute and Stark Law, that accordingly, Fulgent Genetics, Inc was likely to become subject to enhanced legal and regulatory scrutiny, that Fulgent's revenues, to the extent they were derived from the foregoing unlawful conduct, were unsustainable, that the foregoing, once revealed, was likely to subject the Company to significant financial and/or reputational harm, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Fulgent Genetics, Inc. (NASDAQ: FLGT) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in Fulgent Genetics, Inc. (NASDAQ: FLGT) here

News-ID: 2905449 • Views: 228

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Skillsoft Corp. (NYSE: SKIL) …
An investigation on behalf of investors in shares of Skillsoft Corp. (NYSE: SKIL) was announced over potential breaches of fiduciary duties by certain officers and directors at Skillsoft Corp. Investors who purchased shares of Skillsoft Corp. (NYSE: SKIL) s have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Skillsoft Corp. directors breached their fiduciary duties
Investigation announced for Investors who lost money with shares of Edgio, Inc. …
An investigation was announced for investors of Edgio, Inc. (NASDAQ: EGIO) shares over potential securities laws violations by Edgio, Inc. Investors who purchased shares of Edgio, Inc. (NASDAQ: EGIO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Edgio, Inc. (NASDAQ: EGIO) concerning whether a series
Investigation announced for Investors in NASDAQ: SFT shares over potential Wrong …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Shift Technologies, Inc. Investors who purchased shares of Shift Technologies, Inc. (NASDAQ: SFT) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Shift Technologies, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. San
Lawsuit filed for Investors who lost money with shares of Norfolk Southern Corpo …
An investor, who purchased shares of Norfolk Southern Corporation (NYSE: NSC), filed a lawsuit over alleged violations of Federal Securities Laws by Norfolk Southern Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Norfolk Southern Corporation (NYSE: NSC) have certain options and for certain investors are short and strict deadlines running. Deadline: May 15, 2023. NYSE: NSC investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Fulgent

Lawsuit filed for Investors in shares of Fulgent Genetics, Inc. (NASDAQ: FLGT)
An investor, who purchased shares of Fulgent Genetics, Inc. (NASDAQ: FLGT), filed a lawsuit over alleged violations of Federal Securities Laws by Fulgent Genetics, Inc.. Investors who purchased shares of Fulgent Genetics, Inc. (NASDAQ: FLGT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 21, 2022. NASDAQ: FLGT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Temple City based Fulgent
Shoe Manufacturing Service Market Exhibits a Stunning Growth by 2027 with Covid- …
Global market report is a complete depiction of the overall market scenario that covers the effects of the COVID-19 on the market. It covers how this COVID-19 pandemic affected each and every industry of the world. This Shoe Manufacturing Service market report further proceeds with covering market trends, competitive analysis, growth factors, market size, forecast and strategies followed by the key players of the market. It also depicts how
Rare Disease Genetic Testing Market to Witness Huge Growth by 2028 | Fulgent Gen …
Rare Disease Genetic Testing Market size was estimated to be US$ 900 million in 2021 and is expected to reach US$ 2.5 billion by 2028 at a CAGR of +9%. New Report on "Rare Disease Genetic Testing Market" 2021 offers in-depth analysis on industry size, share, drivers and restraints. In addition, this report qualitative study of different segments in terms of inclusive growth, development, opportunity, business strategies, procedures etc. for the
Carrier Screening Market To Witness Huge Growth 2020 | Sema4, Opko Health, Nater …
A recent market study throws light on some of the leading factors that are likely to influence the growth of the Carrier Screening market in the upcoming decade. The well-researched market study touches upon the growth potential of various budding market players in the current Carrier Screening market landscape. Moreover, established players, stakeholders, and investors can leverage the data in the report to formulate effective growth strategies. As per the
Esoteric Testing Market by Top Key Players Foundation Medicine, ACM Global Labor …
Esoteric Testing Market report is an in-depth study on Healthcare IT industry. This report uses SWOT analysis to show the drivers and restrains of Esoteric Testing Market. It includes the recent developments, products launches keeping the track for recent acquisitions, merges, joint ventures and competitive research in the Healthcare IT industry. The report provides comprehensive study on market definition, classifications, applications, engagements, and global industry trends. It’s also main focus
Esoteric Testing Market Industry Insights 2018| Key Players: Genomic Health, ARU …
Infectious disease business segment dominated the esoteric testing market in 2017 with around 28% market share followed by endocrinology, anticipated to witness considerable growth over the coming years. Rising incidences of infectious diseases coupled with growing demand for advanced molecular tests for identifying rare molecules present in the body will drive segment growth. Rising awareness about pre-disease diagnosis and treatment will further stimulate demand for esoteric tests over the coming